General Information of the Compound
Compound ID
CP0504286
Compound Name
2-propyl-N-[(1-pyrazin-2-ylindazol-5-yl)methyl]pentanamide
    Show/Hide
Structure
Formula
C20H25N5O
Molecular Weight
351.454
Canonical SMILES
CCCC(CCC)C(=O)NCc1ccc2n(ncc2c1)-c1cnccn1
    Show/Hide
InChI
InChI=1S/C20H25N5O/c1-3-5-16(6-4-2)20(26)23-12-15-7-8-18-17(11-15)13-24-25(18)19-14-21-9-10-22-19/h7-11,13-14,16H,3-6,12H2,1-2H3,(H,23,26)
    Show/Hide
InChIKey
YDSTUCPHIUUXBH-UHFFFAOYSA-N
Physicochemical Property
logP
3.6481
Rotatable Bonds
8
Heavy Atom Count
26
Polar Areas
72.7
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 45270117
ChEMBL ID
CHEMBL550152
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04361, Protein smoothened
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 > 25000 nM
   TI
   LI
   LO
   TS